An Analysis of Pharmaceutical Lending by the World Bank

An Analysis of Pharmaceutical Lending by the World Bank

The World Bank (WB) began to lend for health, nutrition, and population (HNP) in the late 1970s. Today, the Bank has become the single largest external source of HNP financing in low- and middle-income countries. The Bank's activities in the H...

Full description

Bibliographic Details
Main Authors: Rodríguez-Monguió, Rosa, Rovira, Juan
Format: Working Paper
Language:English
en_US
Published: World Bank, Washington, DC 2013
Subjects:
ANTIBIOTICS
APPRAISAL REPORTS
BORROWER
COMPETITIVE BIDDING
CONCESSIONAL LOANS
CONTRACEPTIVES
COST ACCOUNTING
DEVELOPMENT GOALS
DRUGS
ECONOMICS
EXPENDITURES
FISCAL YEAR
FOREIGN EXCHANGE
HEALTH CARE
HEALTH SECTOR
HEALTH SERVICES
HOSPITALS
HUMAN CAPITAL
INCOME
LEGISLATION
LENDING DOCUMENTS
LENDING INSTRUMENTS
LENDING OPERATIONS
LOAN
LOAN AGREEMENTS
MEDICAL SUPPLIES
MEDICINE
NUTRITION
PHARMACEUTICAL PRODUCTS
PHARMACEUTICAL SECTOR
PHARMACEUTICAL SUPPLIERS
PHARMACEUTICALS
PRIVATE SECTOR
PROCUREMENT
PROJECT IMPLEMENTATION
PUBLIC HEALTH
PUBLIC POLICIES
PURCHASING
RATIONAL USE OF DRUGS
SANITATION
SUPPLIERS
TECHNICAL ASSISTANCE
TRANSPARENCY
TRUST FUNDS
VACCINES
VENEZUELA
WATER SUPPLY
LENDING
Online Access:http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank
http://hdl.handle.net/10986/13730

Internet

http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank
http://hdl.handle.net/10986/13730

Similar Items